American International Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-25,031
| Closed | -$71.1K | – | 144 |
|
2024
Q1 | $71.1K | Sell |
25,031
-215
| -0.9% | -$611 | ﹤0.01% | 2681 |
|
2023
Q4 | $372K | Sell |
25,246
-102
| -0.4% | -$1.5K | ﹤0.01% | 1827 |
|
2023
Q3 | $464K | Buy |
25,348
+901
| +4% | +$16.5K | ﹤0.01% | 1649 |
|
2023
Q2 | $527K | Buy |
24,447
+109
| +0.4% | +$2.35K | ﹤0.01% | 1607 |
|
2023
Q1 | $714K | Buy |
24,338
+485
| +2% | +$14.2K | ﹤0.01% | 1412 |
|
2022
Q4 | $881K | Buy |
23,853
+7,117
| +43% | +$263K | 0.01% | 1269 |
|
2022
Q3 | $471K | Buy |
16,736
+11,368
| +212% | +$320K | ﹤0.01% | 1617 |
|
2022
Q2 | $103K | Buy |
5,368
+608
| +13% | +$11.7K | ﹤0.01% | 2583 |
|
2022
Q1 | $61K | Buy |
+4,760
| New | +$61K | ﹤0.01% | 2773 |
|